Abstract:Background: CASK-related neurodevelopmental disorders are untreatable. Affected children show variable severity, with microcephaly, intellectual disability (ID), and short stature as common features. X-linked human CASK shows dosage sensitivity with haploinsufficiency in females. CASK protein has multiple domains, binding partners, and proposed functions at synapses and in the nucleus. Human and Drosophila CASK show high amino-acid-sequence similarity in all functional domains. Flies homozygous for a hypomorphic CASK mutation (∆18) have motor and cognitive deficits. A Drosophila genetic model of CASK-related disorders could have great scientific and translational value. Methods: We assessed the effects of CASK loss of function on morphological phenotypes in Drosophila using established genetic, histological, and primary neuronal culture approaches. NeuronMetrics software was used to quantify neurite-arbor morphology. Standard nonparametric statistics methods were supplemented by linear mixed effects modeling in some cases. Microfluidic devices of varied dimensions were fabricated and numerous fluid-flow parameters were used to induce oscillatory stress fields on CNS tissue. Dissociation into viable neurons and neurite outgrowth in vitro were assessed. Results: We demonstrated that ∆18 homozygous flies have small brains, small heads, and short bodies. When neurons from developing CASK-mutant CNS were cultured in vitro, they grew small neurite arbors with a distinctive, quantifiable "bushy" morphology that was significantly rescued by transgenic CASK+. As in humans, the bushy phenotype showed dosage-sensitive severity. To overcome the limitations of manual tissue trituration for neuronal culture, we optimized the design and operation of a microfluidic system for standardized, automated dissociation of CNS tissue into individual viable neurons. Neurons from CASK-mutant CNS dissociated in the microfluidic system recapitulate the bushy morphology. Moreover, for any given genotype, device-dissociated neurons grew larger arbors than did manually dissociated neurons. This automated dissociation method is also effective for rodent CNS. Conclusions: These biological and engineering advances set the stage for drug discovery using the Drosophila model of CASK-related disorders. The bushy phenotype provides a cell-based assay for compound screening. Nearly a dozen genes encoding CASK-binding proteins or transcriptional targets also have brain-development mutant phenotypes, including ID. Hence, drugs that improve CASK phenotypes might also benefit children with disorders due to mutant CASK partners.

Modeling Microcephaly with Cerebral Organoids Reveals a WDR62–CEP170–KIF2A Pathway Promoting Cilium Disassembly in Neural Progenitors

Modeling primary microcephaly with human brain organoids reveals fundamental roles of CIT kinase activity

Cerebral organoids expressing mutant actin genes reveal cellular mechanism underlying microcephalic cortical malformation

High-mobility group nucleosomal binding domain 2 protects against microcephaly by maintaining global chromatin accessibility during corticogenesis

Cilia defects upon loss of WDR4 are linked to proteasomal hyperactivity and ubiquitin shortage

Cerebral organoid and mouse models reveal a RAB39b-PI3K-mTOR pathway-dependent dysregulation of cortical development leading to macrocephaly/autism phenotypes.

p53 deletion rescues lethal microcephaly in a mouse model with neural stem cell abscission defects

Cerebral organoids model human brain development and microcephaly

Recapitulating Cortical Development with Organoid Culture in Vitro and Modeling Abnormal Spindle-Like (ASPM Related Primary) Microcephaly Disease

CPAP promotes timely cilium disassembly to maintain neural progenitor pool

Human mutations in NDE1 cause extreme microcephaly with lissencephaly [corrected]

Modeling Hereditary Diffuse Leukoencephalopathy with Axonal Spheroids using microglia-sufficient brain organoids

Severe NDE1-mediated microcephaly results from neural progenitor cell cycle arrests at multiple specific stages

Drosophila CASK regulates brain size and neuronal morphogenesis, providing a genetic model of postnatal microcephaly suitable for drug discovery

KIF5C deficiency causes abnormal cortical neuronal migration, dendritic branching, and spine morphology in mice

A Shared Pathogenic Mechanism for Valproic Acid and SHROOM3 Knockout in a Brain Organoid Model of Neural Tube Defects

Cenpj regulates cilia disassembly and neurogenesis in the developing mouse cortex.

Dnah9 mutant mice and organoid models recapitulate the clinical features of patients with PCD and provide an excellent platform for drug screening

Deficient adaptation to centrosome duplication defects in neural progenitors causes microcephaly and subcortical heterotopias

Epigenetic and Transcriptional Landscapes During Cerebral Cortex Development in a Microcephaly Mouse Model.

WDR62-deficiency Causes Autism-like Behaviors Independent of Microcephaly in Mice